• Categories: ,

    Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma

  • Categories:

    EORTC’s presence at ESTRO 2026

  • independent academic cancer trials
    Categories:

    Independent, academic cancer trials are vital to improve patient outcomes worldwide

  • Diagnostic and Therapeutic Imaging Group

    EORTC Imaging Group Becomes the Diagnostic and Therapeutic Imaging Group

  • Y-ECI programme
    Categories:

    Investing in the future of cancer research; EORTC’s Young and Early Career investigator Network shows its value

  • In Memoriam of Martine Van Glabbeke (1951-2026)

  • Categories:

    PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases

  • Rare disease day rare cancers
    Categories:

    EORTC celebrates Rare Disease Day: Addressing unmet needs in rare cancers